SCHEMBL18285366

SCHEMBL18285366

CCc1nccn1-c1cc(C(=O)NC(C)(C)C2CC2)cc(-c2ccc(F)cc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 1/20 0.38
TTK P33981 1/20 0.37
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
NAMPT P43490 1/20 0.35
HPGDS O60760 1/20 0.35
P2RX3 P56373 1/20 0.35
P2RX2 Q9UBL9 1/20 0.35
F10 P00742 2/20 0.34
SSTR5 P35346 1/20 0.34
GRIN2B Q13224 2/20 0.34
FGFR1 P11362 1/20 0.34
TP53 P04637 1/20 0.34
THRB P10828 1/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
ANO1 Q5XXA6 1/20 0.34
HDAC1 Q13547 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18285357 0.90 MAPT (0.40) WDR5PDE4APDE4BPDE4CPDE4D
SCHEMBL18285293 0.90 P2RY14 (0.40) PDE4APDE4BPDE4CPDE4DNAMPT
SCHEMBL18285364 0.88 RAF1 (0.41) WDR5TTKNAMPTHPGDSFGFR1
SCHEMBL18285346 0.86 WDR5 (0.36) WDR5TTKHPGDSFGFR1CNR1
SCHEMBL18285359 0.86 TTK (0.38) WDR5TTKPDE4APDE4BPDE4C
SCHEMBL18706012 0.83 WDR5 (0.37) WDR5TTKHPGDSFGFR1CNR1
SCHEMBL18285315 0.82 WDR5 (0.34) WDR5TTKP2RX3P2RX2F10
SCHEMBL18285336 0.81 BRAF (0.35) WDR5P2RX3P2RX2F10CNR1
SCHEMBL20921559 0.81 ALDH1A1 (0.39) PDE4APDE4BPDE4CPDE4DP2RX3
SCHEMBL20921747 0.80 PDE4B (0.38) PDE4APDE4BPDE4CPDE4DP2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3303299-B1 IMIDAZOLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2019-04-24 EP claimed
EP-3303299-A1 IMIDAZOLE DERIVATIVES H. Hoffnabb-La Roche Ag (CH) 2018-04-11 EP claimed
WO-2016193235-A1 IMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2016-12-08 WO claimed
EP-3303299-B1 IMIDAZOLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2019-04-24 EP disclosed
US-10029989-B2 Imidazole derivatives HOFFMANN-LA ROCHE INC. (US) 2018-07-24 US disclosed
US-10029989-B2 Imidazole derivatives HOFFMANN-LA ROCHE INC. (US) 2018-07-24 US disclosed
US-20180118692-A1 IMIDAZOLE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2018-05-03 US disclosed
US-20180118692-A1 IMIDAZOLE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2018-05-03 US disclosed
EP-3303299-A1 IMIDAZOLE DERIVATIVES H. Hoffnabb-La Roche Ag (CH) 2018-04-11 EP disclosed
WO-2016193235-A1 IMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2016-12-08 WO disclosed
WO-2016193235-A1 IMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2016-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118692-A1 IMIDAZOLE DERIVATIVES DRD3, GABRR3, DRD4 WDR5 3010/4885TTK 3170/4885PDE4A 2694/4885
US-10029989-B2 Imidazole derivatives DRD3, GABRR3, DRD4 WDR5 3010/4885TTK 3170/4885PDE4A 2694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.